CAHtalyst Study: A Research Study for Adults with Classic Congenital Adrenal Hyperplasia (CAH)

  • days left to enroll
Updated on 23 November 2020
classic congenital adrenal hyperplasia
congenital adrenal hyperplasia


The CAHtalyst Study is a clinical research study evaluating an investigational medication for adults 18 years of age and older who have been diagnosed with classic congenital adrenal hyperplasia (CAH). The investigational medication is an oral capsule that will be taken twice daily with breakfast and evening meals. All participants who qualify will receive the investigational medication, as well as study-related exams and study-related laboratory tests at no cost. Compensation for time and travel may also be available.


Visit to learn more and find out if you prequalify.

Condition Congenital adrenal hyperplasia, Congenital adrenal hyperplasia, Genetic disorders, Rare diseases and disorders, CAH, Congenital Adrenal Hyperplasia
Clinical Study IdentifierTX249732
Last Modified on23 November 2020


Yes No Not Sure

Inclusion Criteria

Be male or female at least 18 years of age
Have a medically confirmed diagnosis of classic CAH
Be on a glucocorticoid dose regimen that has been stable for at least 1 month prior to screening, is greater than a certain dose level, and is intended for chronic use
Not have a condition that requires chronic glucocorticoid treatment (other than CAH)
Not have a clinically significant medical condition or chronic disease (excluding CAH)
Be willing and able to attend the study visits and comply with the research study instructions
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note